Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Grape stems are rich in bioactive phenolic compounds, offering potential for developing antioxidant-rich products in the food industry. The study employed UV-vis spectrophotometry and HPLC to quantify ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Michael Skinnider and his team have developed DeepMet, a large language model–guided program that can assign a structure to ...

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

In its effort to correlate genomic structure with gene function, the 4D Nucleome Consortium (4DN), led by Job Dekker, Ph.D., ...

Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery ...

Inspired by biological systems, materials scientists have long sought to harness self-assembly to build nanomaterials. The ...

AI has changed the way searching happens—and that, in turn, has changed how discovery works. With tools like Perplexity, ChatGPT, and Gemini, the way they crawl the web is completely different from ...

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...